Clay Siegall Is Changing Things Up With Seattle Genetics.

Fighting A Daring Disease

Cancer is one of the most difficult diseases to treat and there simply aren’t enough options for doctors who plan on fighting against it. This is the exact reason that Clay Siegall decided to create Seattle Genetics. He was tired of seeing the lack of progress on fighting cancer and wanted to come up with new and innovative way of approaching the problem. This led him to develop an entirely new treatment method and that innovation has blown up.

A New And Innovative Approach

The center of Seattle Genetics is the antibody-drug conjugate. Combining these qualities together gives this new treatment a much higher rate of success. Previous methods of cancer therapy came with more severe side effects and are less effective than ADCs. ADCs give doctors the ability to treat their patients in a way specifically designed for their immune system in order to allow the body to better accept the drugs. This innovative approach isn’t going unnoticed within the pharmaceutical industry. Seattle Genetics is attracting the attention of big names like Pfizer for its groundbreaking research into cancer.

Where It All Goes From Here

Clay Siegal’s research and hard work are finally paying off. Seattle Genetics is attracting big investments and the interest in its innovative approach has led to a desire to implement ADCs to an even greater extent. To meet these demands Siegall is conducting more research into ADCs and trying to find new applications for them. If he succeeds it just might result in the next big success in cancer therapy. Cancer is one of the most devastating diseases out there, but the assistance of people like Clay Siegall is making a big difference.

About Clay Siegal

Clay Siegall is a medical researcher with a strong focus on cancer. After spending a decade researching cancer for various medical firms he decided to create Seattle Genetics in 1999. Seattle Genetics took off very soon with its innovative approach to fighting cancer and continues to amaze. He continues to use his cancer expertise to deliver new solutions in medicine.